Japan

8 Vaccines Approved for Use in Japan

RNA

Takeda

TAK-919 (Moderna formulation)

Approved in 1 country
2 trials in 1 country
Approval Source: takeda.com
RNA

Pfizer/BioNTech

Comirnaty

Approved in 149 countries
100 trials in 31 countries
Approval Source: japantimes.co.jp
Non Replicating Viral Vector

Oxford/AstraZeneca

Vaxzevria

Approved in 149 countries
73 trials in 34 countries
Approval Source: astrazeneca.com
Protein Subunit

Takeda

TAK-019 (Novavax formulation)

Approved in 1 country
3 trials in 1 country
Approval Source: reuters.com
RNA

Moderna

Spikevax Bivalent Original/Omicron BA.1

Approved in 38 countries
5 trials in 4 countries
Approval Source: stockhouse.com
RNA

Pfizer/BioNTech

Comirnaty Bivalent Original/Omicron BA.1

Approved in 35 countries
3 trials in 5 countries
Approval Source: bloomberg.com
RNA

Pfizer/BioNTech

Comirnaty Bivalent Original/Omicron BA.4/BA.5

Approved in 33 countries
4 trials in 1 country
Approval Source: english.kyodonews.net
RNA

Moderna

Spikevax Bivalent Original/Omicron BA.4/BA.5

Approved in 33 countries
2 trials in 1 country
Approval Source: english.kyodonews.net

15 in Clinical Trials in Japan

Protein Subunit

Shionogi

S-268019

9 trials in 2 countries
VLP

Medicago

Covifenz

Approved in 1 country
6 trials in 6 countries
DNA

AnGes

AG0302-COVID19

8 trials in 1 country
RNA

Daiichi Sankyo Co Ltd

DS-5670a

5 trials in 1 country
RNA

Moderna

Spikevax

Approved in 88 countries
70 trials in 24 countries
RNA

Pfizer/BioNTech

Comirnaty

Approved in 149 countries
100 trials in 31 countries
Non Replicating Viral Vector

Janssen (Johnson & Johnson)

Ad26.COV2.S

Approved in 111 countries
23 trials in 23 countries
Non Replicating Viral Vector

Oxford/AstraZeneca

Vaxzevria

Approved in 149 countries
73 trials in 34 countries
Inactivated

KM Biologics Co Ltd

KD-414

7 trials in 2 countries
Protein Subunit

Takeda

TAK-019 (Novavax formulation)

Approved in 1 country
3 trials in 1 country
DNA

AnGes

AG0301-COVID19

2 trials in 1 country
RNA

Elixirgen Therapeutics Inc

EXG-5003

2 trials in 1 country
RNA

Takeda

TAK-919 (Moderna formulation)

Approved in 1 country
2 trials in 1 country
RNA

VLP Therapeutics Japan

VLPCOV-01

Non Replicating Viral Vector

Janssen (Johnson & Johnson)

Jcovden

Approved in 113 countries
26 trials in 25 countries